Related Experiment Video
Updated: Jun 30, 2026
11:28
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
8.5K
Isolated Frontal Sinus Undifferentiated Carcinoma: First case Report in the Literature
Rajkumar Jain1, Deepak Saharan1, Deepti Sukheeja2
1Department of ORL-HNS, Government medical college, Kota, Rajasthan India.
Summary
This case report details the first instance of isolated frontal sinonasal undifferentiated carcinoma (SNUC). Early surgical intervention and adjuvant therapy are crucial for managing this aggressive tumor.
Area of Science:
- Oncology
- Otorhinolaryngology
Background:
- Sinonasal undifferentiated carcinoma (SNUC) is a rare, aggressive malignancy.
- SNUC presents a distinct clinical course and prognosis compared to other sinonasal cancers.
Purpose of the Study:
- To report the first case of isolated frontal SNUC.
- To highlight the importance of early diagnosis and prompt surgical management for SNUC.
Main Methods:
- A case of isolated frontal SNUC was managed with upfront surgery.
- Adjuvant treatment was administered post-operatively.
Main Results:
- Successful management of an isolated frontal SNUC case.
- Demonstrated the feasibility of upfront surgery followed by adjuvant therapy.
Conclusions:
- Early presentation and timely conservative surgery are vital for improving outcomes in aggressive SNUC.
- This case underscores the significance of prompt intervention in managing sinonasal undifferentiated carcinoma.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...